Browsing: Life Settlements
Longevity and Mortality Investor’s coverage of the life settlement market. We are the leading source globally for life settlement analysis, commentary and insights.
A recent decision by the Delaware Court of Chancery brings some clarity to life settlement investors regarding the statute of limitations in the state. Greg Winterton provides a summary overview of the details.
Decision is a significant positive development for investors in the life settlement industry as it reinforces the enforceability of premium-financed policies where statutory insurable interest requirements are met at inception.
General pace of activity picking up after slow first quarter of 2026.
Complexity in modelling cash flows and risks in longevity-linked assets means challenges for asset managers looking to source capital from US insurers.
James Westerlind, Partner at ArentFox Schiff, dissects the landscape of estate litigation risk in the life settlement market.
New data suggests the average life settlement payout to policyholders is over $200,000.
Industry group the Life Insurance Settlement Association (LISA) has released its 2025 annual market data, showing that consumers who sold their life insurance policies through a LISA member received nearly nine times their cash surrender value.
The brief addresses the significant consumer and market implications of restricting consumer rights found in many convertible term life insurance policies, including preventing the policy owner’s ability to sell their policy in the life settlement marketplace.
Both micro and macro impacts for life settlement market but counterparty fundamentals remain strong.
For life settlement markets, earlier diagnosis of chronic diseases may reduce projected life expectancy, thereby influencing the expected duration of premium payments and the timing of policy maturities.